HEALTH● LOWAug 13 · Aug 13, 2026, 4:48 AM
Biocardia outlines Japan CardiAMP Shonin submission next quarter with approval expected about 12 months later
Seeking Alpha Tech
Biocardia plans to submit its Japan CardiAMP Shonin next quarter, with approval anticipated approximately 12 months later. This outlines a key regulatory milestone for the company's medical technology.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH30m agoAllergic reactions after sex should be listed as an antibiotic risk, experts sayNew ScientistHEALTH34m agoPreliminary reports suspect power leakage into pool from wiring for lights inside poolThe HinduHEALTH1h agoMore than 5,000 die from Ebola in DR Congo's deadliest outbreakBBC WorldHEALTHBREAKING1h agoDR Congo Ebola deaths top 5,000, cases recorded in other African nationsSouth China Morning Post